Dr. Reddy's Laboratories Limited (DRREDDY) Share Analysis
NSE · Healthcare · Pharmaceuticals
Dr. Reddy's Laboratories Limited (NSE: DRREDDY) is an Indian listed company in the Pharmaceuticals sector and a constituent of NIFTY 100, NIFTY 200, NIFTY 50. As of 14 Nov 2026, the share price was ₹1,380.00, P/E 41.2, ROE 11.2%.
Get the AI verdict on DRREDDY: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
DRREDDY chart with trendlines
Is DRREDDY a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Dr. Reddy's Laboratories Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
DRREDDY key facts
| Price and valuation | |
|---|---|
| Share price | ₹1,380.00 |
| Market cap | ₹1.15L Cr |
| P/E ratio | 41.2 |
| P/B ratio | 2.97 |
| EPS | ₹33.55 |
| Book value per share | ₹465.00 |
| Dividend yield | 0.58% |
| 52-week range | |
| 52-week high | ₹1,414.90 |
| 52-week low | ₹1,101.00 |
| Face value | ₹1.00 |
| Shareholding pattern | |
| Promoters | 26.63% |
| FIIs | 20.3% |
| DIIs | 31.87% |
| Public | 20.99% |
Index membership: NIFTY 100, NIFTY 200, NIFTY 50, NIFTY 500, NIFTY Healthcare Index, NIFTY Pharma, NIFTY Quality 30.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.